NEW YORK, NY / ACCESS Newswire / March 23, 2026 / The global wellness economy is valued at $6.3 trillion and is projected to reach $9 trillion by 2028. Yet, most companies continue competing in ...
IN8bio announces INB-619, a novel γδ T cell therapy platform targeting CD19, showing promise in B cell depletion with reduced side effects. IN8bio, Inc. has announced the launch of its innovative γδ T ...
INB.bio Launches 2026 Growth Strategy With New Market Entries Across Africa, MENA and Southeast Asia
BERLIN, March 22, 2026 (GLOBE NEWSWIRE)-- Global demand for wellness products is climbing steadily, with the industry reaching a record $6.8 trillion and projected to hit $9.8 trillion by 2029, and a ...
INB-200 shows significantly improved progression-free survival in glioblastoma patients, with favorable safety profile and no serious toxicities reported. Repeated doses of INB-200 demonstrated an ...
Repeated doses of INB-200 demonstrate extended median progression-free survival (mPFS) of 16.1 months, more than double the expected 6.9 months typically observed with the standard-of-care (SOC) Stupp ...
IN8bio (NASDAQ:INAB) stock rose ~110% on Monday after the company reported data from a phase 1 trial of INB-100 in patients with leukemia. The company said that data showed that 100% of evaluable ...
INB.bio today announced the continued expansion of its nutra wellness ecosystem across emerging markets, strengthening its presence in Africa, the Middle East and North Africa (MENA), South Asia, and ...
INB.bio Launches 2026 Growth Strategy With New Market Entries Across Africa, MENA and Southeast Asia
The MarketWatch News Department was not involved in the creation of this content. BERLIN, March 22, 2026 (GLOBE NEWSWIRE) -- Global demand for wellness products is climbing steadily, with the industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results